Anzeige
Mehr »
Login
Samstag, 05.10.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Citibank´s $3.000-Gold-Prognose und die $60-Millionen-Wette, die den Mining-Sektor neu definieren könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P1SJ | ISIN: GB00BK6JQ137 | Ticker-Symbol:
Branche
Elektrotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
OTAQ PLC Chart 1 Jahr
5-Tage-Chart
OTAQ PLC 5-Tage-Chart
Dow Jones News
371 Leser
Artikel bewerten:
(2)

OTAQ Plc: SIP Purchase, PDMR and Total Voting Rights

DJ SIP Purchase, PDMR and Total Voting Rights

OTAQ Plc (OTAQ) 
SIP Purchase, PDMR and Total Voting Rights 
17-Sep-2024 / 20:06 GMT/BST 
=---------------------------------------------------------------------------------------------------------------------- 
17 September 2024 
OTAQ plc 
("OTAQ", or the "Company") 
 
Share Incentive Plan Purchase 
 
Director/PDMR Shareholding 
 
Total Voting Rights 
 
OTAQ plc (OTAQ.AQ), the innovative technology company targeting the aquaculture and offshore markets, received 
notification on 16 September 2024 from Cytec Solutions Corporate Trustees Limited (the "SIP Trustee") in relation to 
the issue and allotment of 43,999 ordinary shares of 1 penny each in the Company ("Ordinary Shares") for the benefit of 
participants of the OTAQ Share Incentive Plan (the "SIP"), including Persons Discharging Managerial Responsibilities in 
the Company ("PDMR") outlined below in accordance with the rules of the SIP (the "SIP Award"). 
 
The SIP is an all-employee trust arrangement approved by HM Revenue and Customs, under which each participating 
employee will acquire Ordinary Shares at the prevailing market price per share using contributions deducted from 
pre-tax salary in each calendar month ("Partnership Shares"), with each participating employee being awarded one 
Ordinary Share for each Partnership Share ("Matching Shares"), using newly issued shares. 
 
Details of the number of Partnership Shares purchased by each of the PDMRs at a price of 3.75 pence per Ordinary Share, 
and the number of Matching Shares allocated by the SIP Trustee to the PDMRs for no consideration, is set out against 
their names in the table below. 
               Number of     Number of    Total beneficial holding  Percentage beneficial holding 
Name     Title     Partnership    Matching Shares following Admission    following Admission 
               Shares 
       Chief 
Philip Newby* Executive   4,000       4,000      1,514,712         1.18% 
       Officer 
       Chief 
Justine Dowds Financial   4,000       4,000      23,286          0.02% 
       Officer 

*Philip Newby's beneficial holding includes 349,606 Ordinary Shares held by his wife, Diane Newby

The SIP Award has in part been satisfied by the issue of 43,999 new Ordinary Shares (the "SIP Shares") to the SIP Trustee. The SIP Shares shall rank pari passu in all respects with the Company's existing ordinary shares in issue. Application has been made to the Aquis Stock Exchange for the SIP Shares to be admitted to trading on the Access Segment of the AQSE Growth Market ("Admission"). It is expected that Admission will become effective on or around 8.00 a.m. on 23 September 2024.

Total Voting Rights

Following Admission, the Company will have 128,525,039 Ordinary Shares in issue, with voting rights. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares in the Company with voting rights will be 128,525,039.

This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Enquiries:

OTAQ PLC                      +44 (0) 1524 748028 
Adam Reynolds, Non-Executive Chairman 
Phil Newby, Chief Executive Officer 
 
Justine Dowds, Chief Financial Officer 
 
Dowgate Capital Limited - AQSE Corporate Advisor & Broker +44 (0)20 3903 7715 
David Poutney / James Serjeant 
 
Nicholas Chambers / Russell Cook 
 
                          +44 (0)20 7933 8780 
Walbrook PR Limited - PR 
                          07971221972 or 07748325236 
Tom Cooper / Nick Rome               OTAQ@walbrookpr.com 
 

About OTAQ

OTAQ is a highly innovative technology company targeting the aquaculture and offshore markets. It already has a number of established products in its portfolio and is focused on further developing its presence, customer base and cross selling opportunities within core markets both organically and via acquisition.

OTAQ's aquaculture products, which include a sonar device (developed for Minnowtech LLC) to scan shrimp in ponds and water quality monitoring, are focused on maximising welfare and production yields. Additionally, the Company is developing a potentially game changing live plankton analysis product for finfish and shellfish farmers. It also continues to target opportunities in the acoustic deterrent devices market via its Sealfence product, which is used by salmon farmers, with global opportunities in Chile, Australia, Canada and Norway.

OTAQ's offshore product range includes OceanSense subsea leak detection, Eagle IP camera systems, Lander seabed survey devices and Subsea electrical connectors and penetrators. It is targeting a number of growth opportunities in new territories and has a strong client base including Expro, Amphenol and National Oilwell Varco. The Company is also focused on the development of new products through this division, with the aim of increased cross-deployment of skills and technologies into the aquaculture arena.

The Company is also developing high accuracy location trackers for specialist applications. Having already added clients within safety and multiple participant sport/racing applications, the Company is investigating wider market potential - including opportunities in the seafood industry.

The Company makes this announcement, including the notification(s) below, in accordance with the requirements of the EU Market Abuse Regulation.

1       Details of the person discharging managerial responsibilities / person closely associated 
 
       Name 
a)                         Philip Newby 
 
2       Reason for the notification 
 
a)      Position/status           Chief Executive Officer and PDMR 
 
b)      Initial notification /Amendment 
                          Initial Notification 
 
3       Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction 
       monitor 
 
 
a)      Name 
                          OTAQ plc 
 
b)      LEI 
                          213800CZGMYB5XTUXJ52 
 
4       Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 
 
       Description of the financial     Ordinary shares of 1 penny each 
       instrument, type of instrument 
 
a) 
 
       Identification code 
                          ISIN: GB00BK6JQ137 
 
 
       Nature of the transaction 
b)                         Purchase and allocation of Partnership and Matching Shares (no 
                          consideration), respectively, under the OTAQ SIP. 
 
 
 
                          Price(s) 
                                 Volume(s) 
 
c)      Price(s) and volume(s) 
                          3.75p     4,000 
 
                          Nil      4,000 
 
       Aggregated information      Price(s) 
d)                              Aggregated volume (s) 
 
 
                        1.875p    8,000 

e) Date of the transaction

16 September 2024

f) Place of the transaction

Aquis Stock Exchange (AQSE)

1       Details of the person discharging managerial responsibilities / person closely associated 
 
       Name 
a)                         Justine Dowds 
 
2       Reason for the notification 
 
a)      Position/status           Chief Financial Officer and PDMR 
 
b)      Initial notification /Amendment 
                          Initial Notification 
 
3       Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction 
       monitor 
 
 
a)      Name 
                          OTAQ plc 
 
b)      LEI 
                          213800CZGMYB5XTUXJ52 
 
4       Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 
 
       Description of the financial     Ordinary shares of 1 penny each 
       instrument, type of instrument 
 
a) 
 
       Identification code 
                          ISIN: GB00BK6JQ137 
 
 
       Nature of the transaction 
b)                         Purchase and allocation of Partnership and Matching Shares (no 
                          consideration), respectively, under the OTAQ SIP. 
 
 
 
                          Price(s) 
                                 Volume(s) 
 
c)      Price(s) and volume(s) 
                          3.75p     4,000 
 
                          Nil      4,000 
 
       Aggregated information      Price(s) 
d)                              Aggregated volume (s) 
 
 
                        1.875p    8,000 

e) Date of the transaction

16 September 2024

f) Place of the transaction

Aquis Stock Exchange (AQSE)

----------------------------------------------------------------------------------------------------------------------- Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

ISIN:     GB00BK6JQ137 
Category Code: MSCL 
TIDM:     OTAQ 
LEI Code:   213800CZGMYB5XTUXJ52 
Sequence No.: 347411 
EQS News ID:  1990059 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------
 

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1990059&application_name=news&site_id=dow_jones%7e%7e%7ef1066a31-ca00-4e1a-b0a4-374bd7d0face

(END) Dow Jones Newswires

September 17, 2024 15:06 ET (19:06 GMT)

© 2024 Dow Jones News
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.